Viewing Study NCT01982357


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2026-01-02 @ 11:14 AM
Study NCT ID: NCT01982357
Status: COMPLETED
Last Update Posted: 2022-11-01
First Post: 2013-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies
Sponsor: University of California, Irvine
Organization:

Study Overview

Official Title: Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies
Status: COMPLETED
Status Verified Date: 2022-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Alterations to microvascular blood flow in premature infants, are known to contribute to several major disease entities.

The optically-measured tissue blood flow, to determine tissue perfusion that can be use to detect blood loss.
Detailed Description: The researchers want to use optical technologies to non-invasively detect blood flow that can tell the onset of blood loss. The research can measure blood flow in stable premature infants in the Neonatal Intensive Care Unit over the duration of several weeks.

The technologies are Laser Speckle Imaging and Diffuse Optical Spectroscopy.

Laser Speckle Imaging non-contact imaging technology, is sensitive to blood flow in superficial tissues. Diffuse Optical Spectroscopy, a probe-based contact technology like pulse oximetry, measures hemoglobin concentrations and states deeper below the skin surface.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: